Yugo Kai

DNase II activated by the mitochondrial apoptotic pathway regulates RIP1-dependent non-apoptotic hepatocyte death via the TLR9/IFN-β signaling pathway

Yoshinobu Saito, Hayato Hikita, Yasutoshi Nozaki et al. · Cell Death and Differentiation · 2018 · 60 citations · Full text

Dnase Ii, Mitochondrial Function, Medicine +8

Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment

Yugo Kai, Hayato Hikita, Naoki Morishita et al. · Scientific Reports · 2017 · 34 citations · Full text

Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment

Kenji Ikezawa, Makiko Urabe, Yugo Kai et al. · Japanese Journal of Clinical Oncology · 2023 · 34 citations · Full text

Success rate of microsatellite instability examination and complete response with pembrolizumab in biliary tract cancer

Yugo Kai, Kenji Ikezawa, Ryoji Takada et al. · JGH Open · 2021 · 33 citations · Full text

Emergence of hepatitis C virus NS5A L31V plus Y93H variant upon treatment failure of daclatasvir and asunaprevir is relatively resistant to ledipasvir and NS5B polymerase nucleotide inhibitor GS-558093 in human hepatocyte chimeric mice

Yugo Kai, Hayato Hikita, Tomohide Tatsumi et al. · Journal of Gastroenterology · 2015 · 31 citations

Inhibitor Gs-558093, Molecular Virology, Hepatology +11